Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings

被引：0
作者：
Capstick, Toby [1 ]
Hurst, Rhys [2 ]
Keane, Jennie [3 ]
Musaddaq, Besma [4 ]
机构：
[1] St James Univ Hosp, Leeds LS9 7TF, England
[2] Royal Papworth Hosp NHS Fdn Trust, Cambridge CB2 0AY, England
[3] Essex Partnership Univ NHS Fdn Trust EPUT, Rochford SS4 1DD, England
[4] Royal Free Hosp NHS Fdn Trust, Dept Radiol, London NW3 2QG, England
来源：
PHARMACY | 2024年 / 12卷 / 04期
关键词：
nontuberculous mycobacteria; pulmonary disease; NTM-PD; Mycobacterium avium complex; COMPLEX LUNG-DISEASE; INFECTION; ASSOCIATION; MANAGEMENT; DIAGNOSIS; IMPACT; RISK; GENE;
D O I：
10.3390/pharmacy12040126
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Nontuberculous mycobacterial pulmonary disease (NTM-PD) results from opportunistic lung infections by mycobacteria other than Mycobacterium tuberculosis or Mycobacterium leprae species. Similar to many other countries, the incidence of NTM-PD in the United Kingdom (UK) is on the rise for reasons that are yet to be determined. Despite guidelines established by the American Thoracic Society (ATS), the Infectious Diseases Society of America, and the British Thoracic Society, NTM-PD diagnosis and management remain a significant clinical challenge. In this review article, we comprehensively discuss key challenges in NTM-PD diagnosis and management, focusing on the UK healthcare setting. We also propose countermeasures to overcome these challenges and improve the detection and treatment of patients with NTM-PD.
引用
收藏
页数：17
相关论文
共 85 条
[11]   Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections [J].
Choi, Yeonseok ;
Jhun, Byung Woo ;
Kim, Jhingook ;
Huh, Hee Jae ;
Lee, Nam Yong .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
[12]   The role of clinical pharmacists in general practice in England: Impact, perspectives, barriers and facilitators [J].
Claire, Mann ;
Claire, Anderson ;
Matthew, Boyd .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (08) :3432-3437
[13]   Non-tuberculous mycobacterial pulmonary disease [J].
Cowman, Steven ;
van Ingen, Jakko ;
Griffith, David E. ;
Loebinger, Michael R. .
EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
[14]   The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex [J].
Crilly, Nathan P. ;
Ayeh, Samuel K. ;
Karakousis, Petros C. .
FRONTIERS IN IMMUNOLOGY, 2021, 11
[15]   Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review [J].
Dahl, Victor Naestholt ;
Molhave, Martin ;
Floe, Andreas ;
van Ingen, Jakko ;
Schon, Thomas ;
Lillebaek, Troels ;
Andersen, Aase Bengaard ;
Wejse, Christian .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 125 :120-131
[16]   Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary [J].
Daley, Charles L. ;
Iaccarino, Jonathan M. ;
Lange, Christoph ;
Cambau, Emmanuelle ;
Wallace, Richard J., Jr. ;
Andrejak, Claire ;
Bottger, Erik C. ;
Brozek, Jan ;
Griffith, David E. ;
Guglielmetti, Lorenzo ;
Huitt, Gwen A. ;
Knight, Shandra L. ;
Leitman, Philip ;
Marras, Theodore K. ;
Olivier, Kenneth N. ;
Santin, Miguel ;
Stout, Jason E. ;
Tortoli, Enrico ;
van Ingen, Jakko ;
Wagner, Dirk ;
Winthrop, Kevin L. .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) :E1-E36
[17]   Identification of potentially undiagnosed patients with nontuberculous mycobacteria lung disease using machine learning applied to primary care data in the UK [J].
Doyle, Orla M. ;
van der Laan, Roald ;
Obradovic, Marko ;
McMahon, Peter ;
Daniels, Flora ;
Pitcher, Ashley ;
Loebinger, Michael R. .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
[18]   Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease [J].
Farnia, Poopak ;
Ghanavi, Jalaledin ;
Saif, Shima ;
Farnia, Parissa ;
Velayati, Ali Akbar .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (01) :57-61
[19]  
Finch S, 2019, Thorax, V74, pA238, DOI [DOI 10.1136/THORAX-2019-BTSABSTRACTS2019.416, 10.1136/thorax-2019-BTSabstracts2019.416]
[20]   US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis [J].
Floto, R. Andres ;
Olivier, Kenneth N. ;
Saiman, Lisa ;
Daley, Charles L. ;
Herrmann, Jean-Louis ;
Nick, Jerry A. ;
Noone, Peadar G. ;
Bilton, Diana ;
Corris, Paul ;
Gibson, Ronald L. ;
Hempstead, Sarah E. ;
Koetz, Karsten ;
Sabadosa, Kathryn A. ;
Sermet-Gaudelus, Isabelle ;
Smyth, Alan R. ;
van Ingen, Jakko ;
Wallace, Richard J. ;
Winthrop, Kevin L. ;
Marshall, Bruce C. ;
Haworth, Charles S. .
THORAX, 2016, 71 :1-22
123456789